Incremental direct and indirect costs of untreated vasomotor symptoms

Menopause

Volumn 22, Issue 3, 2015, Pages 260-266

  Sarrel, Philip ^a   Portman, David ^b   Lefebvre, Patrick ^c   Lafeuille, Marie Hélène ^c   Grittner, Amanda Melina ^c   Fortier, Jonathan ^c   Gravel, Jonathan ^c   Duh, Mei Sheng ^d   Aupperle, Peter M ^e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Columbus Center for Women's Health Research ^*  (United States)

^c Groupe d analyse   (Canada)

^d ANALYSIS GROUP   (United States)

^e Noven Pharmaceuticals Inc   (United States)

Author keywords

Costs; Menopause; Vasomotor symptoms; Work productivity

Indexed keywords

ABSENTEEISM; ADULT; AGED; ANXIETY DISORDER; ARTICLE; BREAST CANCER; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; COST OF ILLNESS; DEPRESSION; DISABILITY; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; INCREMENTAL DIRECT COSTS OF ILLNESS; INDIRECT COST OF ILLNESS; MAJOR CLINICAL STUDY; MIDDLE AGED; OUTPATIENT CARE; PRODUCTIVITY; RETROSPECTIVE STUDY; VASOMOTOR DISORDER; ADOLESCENT; AMBULATORY CARE; COST; ECONOMICS; EVALUATION STUDY; HOT FLUSH; PATIENT ATTITUDE; PROPENSITY SCORE; STATISTICAL ANALYSIS; STATISTICS AND NUMERICAL DATA; UTILIZATION; YOUNG ADULT;

ABSENTEEISM; ADOLESCENT; ADULT; AGED; AMBULATORY CARE; COSTS AND COST ANALYSIS; DIRECT SERVICE COSTS; EFFICIENCY; FEMALE; HEALTH EXPENDITURES; HOT FLASHES; HUMANS; INSURANCE, HEALTH; MATCHED-PAIR ANALYSIS; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PROPENSITY SCORE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84924324916     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000320     Document Type: Article

References (34)

1. United States Department of Labor. Women at work. Available at: http:// www.bls.gov/spotlight/2011/women/. Accessed June 26, 2014.
2. Solis H, Hall K. Women in the labor force: a databook. US Bureau of Labor Statistics Website. Available at: http://www.bls.gov/cps/wlfdatabook-2011.pdf. Report 1034. Published December 2011.
3. La Rosa JH. Women, work, and health: employment as a risk factor for coronary heart disease. Am J Obstet Gynecol 1988;158:1597-1602.
4. Ilmarinen J. Towards a longer worklife: ageing and the quality of worklife in the European Union. Helsinki, Finland: Finnish Institute of Occupational Health, Ministry of Social Affairs and Health; 2005.
5. Kim HS, Sherman DK, Taylor SE. Culture and social support. Am Psychol 2008;63:518-526.
6. National Institute on Aging. Menopause: time for a change. Available at: http://www.nia.nih.gov/health/publication/menopause-Time-change/ introduction-menopause. Accessed June 26, 2014.
7. Merrill RM. Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit 2008;14:CR24-CR31.
8. Whiteman MK, Hillis SD, Jamieson DJ, et al. Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol 2008; 198:34.e1-34.e7.
9. Utian WH. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Health Qual Life Outcomes 2005;3:47-54.
10. Schmidt P. The 2012 hormone therapy position statement of The North American Menopause Society. Menopause 2012;19:257-271.
11. Ayers B, Hunter MS. Health-related quality of life of women with menopausal hot flushes and night sweats. Climacteric 2013;16:235-239.
12. Van Dole KB, Williams RE, Brown RS, Gaynes B, Devellis R, Funk MJ. Longitudinal association of vasomotor symptoms and psychosocial outcomes among postmenopausal women in the United States: a populationbased study. Menopause 2010;17:917-923.
13. Sarrel P, Rousseau M, Mazure C, Glazer W. Ovarian steroids and the capacity to function at home and in the workplace. Ann N Y Acad Sci 1990;592:156-161, discussion 185-192.
14. Geukes M, van Aalst MP, Nauta MCE, Oosterhof H. The impact of menopausal symptoms on work ability. Menopause 2012;19:278-282.
15. Griffiths A, Maclennan SJ, Hassard J. Menopause and work: an electronic survey of employees' attitudes in the UK. Maturitas 2013;76:155-159.
16. Kleinman NL, Rohrbacker NJ, Bushmakin AG, Whiteley J, Lynch WD, Shah SN. Direct and indirect costs of women diagnosed with menopause symptoms. J Occup Environ Med 2013;55:465-470.
17. Whiteley J, Wagner J-S, Bushmakin A, Kopenhafer L, Dibonaventura M, Racketa J. Impact of the severity of vasomotor symptoms on health status, resource use, and productivity. Menopause 2013;20:518-524.
18. Dibonaventura MD, Chandran A, Hsu M-A, Bushmakin A. Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom. Int J Womens Health 2013;5:261-269.
19. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
20. Sprague BL, Trentham-Dietz A, Cronin KA. A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010. Obstet Gynecol 2012;120:595-603.
21. Williams RE, Kalilani L, DiBenedetti DB, Zhou X, Fehnel SE, Clark R V. Healthcare seeking and treatment for menopausal symptoms in the United States. Maturitas 2007;58:348-358.
22. The Endocrine Society. First of its kind BMenopause Map[ helps women navigate treatment. Available at: https://www.endocrine.org/news-room/ press-release-Archives/2012/first-of-its-kind-menopause-map-helpswomen-navigate-Treatment. Accessed June 26, 2014.
23. Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput 2009;38:1228-1234.
24. Mooney CZ, Duval RD, Duvall R. Bootstrapping: A Nonparametric Approach to Statistical Inference. Newbury Park, CA: Sage; 1993.
25. Roth JA, Etzioni R, Waters TM, et al. Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study. Ann Intern Med 2014;160:594-602.
26. Nelson HD. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. JAMA 2004;291:1610-1620.
27. Hunter M, Battersby R, Whitehead M. Relationships between psychological symptoms, somatic complaints and menopausal status. Maturitas 1986;8:217-228.
28. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006;63:375-382.
29. Bromberger JT, Kravitz HM, Chang Y, et al. Does risk for anxiety increase during the menopausal transition? Study of Women's Health Across the Nation. Menopause 2013;20:488-495.
30. Cray LA, Woods NF, Herting JR, Mitchell ES. Symptom clusters during the late reproductive stage through the early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause 2012;19:864-869.
31. Duffy OK, Iversen L, Aucott L, Hannaford PC. Factors associated with resilience or vulnerability to hot flushes and night sweats during the menopausal transition. Menopause 2013;20:383-392.
32. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, Matthews KA. Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study. Circulation 2008;118:1234-1240.
33. Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-1477.
34. Dennerstein L, Smith AM, Morse C, et al. Menopausal symptoms in Australian women. Med J Aust 1993;159:232-236.